A prospective randomised controlled trial of Vypro II and TiMesh in inguinal hernia repair using the total extraperitoneal endoscopic approach

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN96288558

Enrollment

350

Registered

2005-11-24

Start date

2004-01-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal hernia. Surgery Inguinal hernia

Interventions

Total endoscopic extraperitoneal hernia repair with either TiMesh or Vypro II.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Male gender 2. Primary bilateral hernia 3. Recurrent unilateral hernia 4. Primary unilateral hernia 5. Age >18 years 6. Consent to the study

Exclusion criteria

Exclusion criteria: 1. Female gender 2. Change of diagnosis during operation (e.g. femoral hernia) 3. Change of operative procedure during operation (e.g. TAPP)

Design outcomes

Primary

Measure	Time frame
Inguinal pain and discomfort at 6 weeks and 2 years.	—

Secondary

Measure	Time frame
1. Hernia recurrence 2. Complications 3. Quality of life	—

Countries

Switzerland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026